Shipping:
£ 3.12
Within U.S.A.
Book Description Condition: New. Seller Inventory # ABLIING23Apr0316110291838
Book Description PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786204080697
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9786204080697_lsuk
Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9786204080697
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Appropriate effective therapy is the essential goal of the implantable automatic defibrillator. The occurrence of inappropriate therapy is a potentially serious event. Methods:We conducted a study that included 80 patients implanted with ICDs in the cardiology department of Habib Thameur Hospital in Tunis between January 2010 and June 2019. Results:The median age of the patients was 58 years (52.25-65.75) with a sex ratio of 12.1H/F. During a median follow-up of 48 months, 695 therapies were recorded: 62% anti-tachycardia pacing (ATP) and 38% shocks with a predominance of appropriate therapies (87.8%).The incidence of therapies was 4.72 therapies/patient-year at 1 year, 3.28 therapies/patient-year at 3 years and 0.78 therapies/patient-year at 5 years. In multivariate analysis, the independent predictors of death were inappropriate therapy (RR = 1.102 with a 95% CI of (1.026-1.184), p=0.008), ischemic heart disease (RR = 2.965 with a 95% CI of (0.931-9.444), p=0.066), and LVEF less than 29% (RR = 2.340 with a 95% CI of (0.942-5.809), p=0.067). 96 pp. Englisch. Seller Inventory # 9786204080697
Book Description PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # L0-9786204080697
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Appropriate effective therapy is the essential goal of the implantable automatic defibrillator. The occurrence of inappropriate therapy is a potentially serious event. Methods:We conducted a study that included 80 patients implanted with ICDs in the cardiology department of Habib Thameur Hospital in Tunis between January 2010 and June 2019. Results:The median age of the patients was 58 years (52.25-65.75) with a sex ratio of 12.1H/F. During a median follow-up of 48 months, 695 therapies were recorded: 62% anti-tachycardia pacing (ATP) and 38% shocks with a predominance of appropriate therapies (87.8%).The incidence of therapies was 4.72 therapies/patient-year at 1 year, 3.28 therapies/patient-year at 3 years and 0.78 therapies/patient-year at 5 years. In multivariate analysis, the independent predictors of death were inappropriate therapy (RR = 1.102 with a 95% CI of (1.026-1.184), p=0.008), ischemic heart disease (RR = 2.965 with a 95% CI of (0.931-9.444), p=0.066), and LVEF less than 29% (RR = 2.340 with a 95% CI of (0.942-5.809), p=0.067). Seller Inventory # 9786204080697
Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Appropriate effective therapy is the essential goal of the implantable automatic defibrillator. The occurrence of inappropriate therapy is a potentially serious event. Methods:We conducted a study that included 80 patients implanted with ICDs in the cardiol. Seller Inventory # 509336903